In this segment of Spotlight In Focus, Psychedelic Spotlight’s Matthew Dunehoo discusses the importance of music in alleviating mental health illnesses with Numinus Wellness CEO Payton Nyquvest. They discuss how music intertwines with psychedelic therapy and how it could be used
as a tool for building a community and awareness in this emerging sector.

In May of 2022, NUMINUS WELLNESS sponsored the first in a series of immersive healing sound events entitled MUSIC AS MEDICINE. It was an immersive meditative musical experience and consciousness-expanding visuals featuring Jon Hopkins, East Forest and Superposition.

Olive Kimoto, East Forest, Superposition and Jon Hopkins each shared the stage to engage an audience, present with the intention to heal, with waves of lushly composed ambient and electronic sounds, delivered through high end audio and augmented by evocative visual projections.

To learn more about MUSIC AS MEDICINE, visit:
⏯ https://numinus.com/music-as-medicine-event/

#Music #Psychedelics #Numinus

source

Similar Posts

BIG UPDATE On The LARGEST Psychedelic Therapy Clinical Trial: CMPS’ Psilocybin-Depression Study

BIG UPDATE On The LARGEST Psychedelic Therapy Clinical Trial: CMPS’ Psilocybin-Depression Study

Listen, Videos

HUGE UPDATE: Compass Pathways, (NASDAQ: CMPS), completes the LARGEST Phase 2b psilocybin clinical study to treat treatment resistant depression (TRD).

This is the most important psychedelic therapy study that we know of because it is both the largest clinical trial testing psilocybin to date and it is also the most advanced in the clinical trial process.

In this episode we will discuss:
– The details of this trial and why it is so important;
– The big update that we have for you;
– When we can expect results;
– Where the field goes from here in the near future.

Timestamps:

0:00 – Intro
1:31 – What is Compass Pathways’ Phase2b trial and why is it important?
6:57 – The major Update on CMPS’ Clinical Trial
8:07 – Anticipated results date & what these results will mean for the psychedelic industry

Enjoy the episode!

Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor

Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com

Music from:
www.bensound.com

Video editing: @themyaholy

Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#CompassPathways #CMPS #PsychedelicTherapy

Removing Barriers of Accessibility to Psychedelics with Brett Waters

Removing Barriers of Accessibility to Psychedelics with Brett Waters

Listen, Podcasts

Brett also introduces the collaborative efforts of Reason for Hope’s team, which includes strategic minds from various fields, working together in drafting legislation, preparing legal briefings, educating legislators, and building advocacy coalitions. Currently, Reason for Hope focuses on establishing MDMA- and psilocybin-assisted therapy expanded access pilot programs for those unable to wait for FDA approval.

Interview With Rabbi Zac Kamenetz

Interview With Rabbi Zac Kamenetz

Listen, Podcasts

Founder and CEO of Shefa, and Co-Founder of the Jewish Psychedelic Summit, Rabbi Zac Kamenetz, speaks about the upcoming summit and the connection between Judaism and psychedelics.